LuPSMA
novartis
['prostate']
vision trial: exploratory post-hoc analysis. lu-psma benefit is independent of prior or concomitant treatments but os seems prolonged if 1 vs &gt;1 previous taxane and concurrent arpi as part of soc #asco22 #prostatecancer 
Jefe de Servicio de Oncología Médica y Coordinador de ORT del Área Sanitaria de Lugo, A Mariña e Monforte de Lemos. Transdisciplinar y Transideológico.